KRT18 and metabolic dysfunction-associated steatotic liver disease: Given the close relationship between NAFLD and CVD, and the sensitivity of CK18 to hepatocellular injury and inflammatory signaling, serum CK18 may provide a novel and practical approach for identifying NAFLD patients with coexisting cardiovascular complications, thereby supporting improved clinical evaluation and management.